Seeking Alpha
View as an RSS Feed


View DoctoRx's Articles BY TICKER:
Show Summaries  |  Hide Summaries
  • Why I Bought The Dips In Both Gilead And Achillion Today
    Editors' Pick  • Wed, May 20 ACHN, GILD 156 Comments
  • A Critique Of Carl Icahn's Apple Fair Value Revaluation To $240 Per Share
    Tue, May 19 AAPL 109 Comments
  • Regeneron Beats, Raises And Accelerates Its Late-Stage Product Development
    Editors' Pick  • Mon, May 11 REGN 30 Comments
  • Celgene's Plan For Life After Revlimid, With Discussion Of Q1 Earnings
    Mon, May 4 CELG 33 Comments
  • Gilead Proves Golden: The Importance Of Its Beat-And-Raise Quarter
    Fri, May 1 GILD 142 Comments
  • The Case That Apple Is Worth At Least $200 A Share
    Mon, Apr. 27 AAPL 206 Comments
  • Why I Bought The Biogen Dip
    Mon, Apr. 27 BIIB 48 Comments
  • An Analysis Of Acceleron, A Development-Stage Celgene Partner
       • Wed, Apr. 22 XLRN 11 Comments
  • A Discussion Of Amgen's Q1 Results, With Updates On Its Pipeline
    Wed, Apr. 22 AMGN 14 Comments
  • Celgene: A Pre-Earnings Discussion Based On Recent News
     • Fri, Apr. 17 CELG 37 Comments
  • Why Portola's Andexanet In Phase 3 May Be Worth Much More Than Its Market Cap
       • Tue, Apr. 14 PTLA 60 Comments
  • Lumber Prices Fall Sharply: Implications For Bonds And Different Stock Market Sectors
    Tue, Apr. 14 AAPL, GILD, ITB 41 Comments
  • Is Biogen A Buy? An Analysis Of Its Growth Drivers And Challenges
    Thu, Apr. 9 BIIB 44 Comments
  • A Pre-Earnings Update On Gilead
       • Wed, Apr. 1 GILD 181 Comments
  • Why This Reinsurer Is Poised For Continued Outperformance
    Tue, Mar. 31 RE 27 Comments
  • The Investment Case For The EURO STOXX 50
    Editors' Pick  • Wed, Mar. 25 FEZ 15 Comments
  • Cat-astrophe? No, But There Is A Good Case Against Caterpillar Shares
       • Tue, Mar. 17 CAT 47 Comments
  • Unexpected Bullish Catalysts From Apple's Latest Event: Implications For The Stock
    Tue, Mar. 10 AAPL 62 Comments
  • The Case For A Trading Shift From Stocks To Treasuries
    Tue, Mar. 3 ED, EDV, IEF 35 Comments
  • Is It Safe To Buy Treasuries Yet?
    Fri, Feb. 20 TLT 78 Comments
  • The Real Importance Of The Apple Car Project
    Fri, Feb. 20 AAPL 172 Comments
  • Celgene: A Follow-Up To My Bullish Article Of Last Spring
    Tue, Feb. 17 CELG 23 Comments
  • Why Regeneron's Risk-Reward Looks Good Again
       • Fri, Feb. 13 REGN 40 Comments
  • More Good News: Update On Portola As The Stock Pushes Toward All-Time Highs
       • Fri, Feb. 13 PTLA 28 Comments
  • Comments On Gilead's Quarter And The Road Ahead
    Editors' Pick  • Wed, Feb. 11 GILD 126 Comments
  • Some Pre-Earnings Release Observations About Gilead Sciences
    Editors' Pick  • Mon, Feb. 2 GILD 129 Comments
  • Trinity Industries: Legal And Business Update, With Discussion Of A Bullish Investment Thesis
    Editors' Pick  • Wed, Jan. 21 TRN 65 Comments
  • New Reason Appears For Yahoo Investors To Fear Alibaba's Business Structure
    Tue, Jan. 20 YHOO, BABA 73 Comments
  • Gilead: A Bullish Update
    Fri, Jan. 16 GILD 223 Comments
  • Are Housing Stocks Ready To Rock Or Roll Over?
    Thu, Jan. 15 HD, HOV, LEN 12 Comments
  • A Potentially Optimal Long Tactic For Treasury Bond Investors
    Wed, Jan. 14 EDV, IEF, SPY 4 Comments
  • Is A Bullish 'Perfect Storm' Brewing In Treasury Bonds?
    Editors' Pick  • Tue, Jan. 6 EDV, IEF, IEI 79 Comments